-
Previous investigation of cervical cancer biology has revealed a dependence on VEGF, among other factors, for growth and metastases.
-
New information from two case control studies of the transdermal contraceptive (Ortho Evra, Ortho-McNeil Pharmaceutical, Raritan, NJ) indicates no increased risk of heart attack or stroke for women who choose the patch, but data conflict on the occurrence of venous thromboembolism (VTE).
-
The woman sitting in front of you says for about 10 days of every month, she experiences depression, marked anxiety, sudden mood shifts, persistent irritability, and bloating.
-
A patient tells you she heard a news story that said that oral contraceptives (OCs) have lasting effect on hormone levels, dulling a womans sexual desire. What is your response?
-
Start making plans for the 2006 National Womens Health Week Celebration, May 14-20.
-
While senior citizens may be wise in many subjects, when it comes to knowledge of HIV risk, they may be operating in the dark. Results of a survey of women ages 50 and older indicate seniors have limited knowledge when it comes to sexual transmission of HIV.
-
When it comes to weight, patients may discontinue use of hormonal contraception if extra pounds are encountered. Can the method be the culprit?
-
You deliver some bad news to your next patient, a 16-year-old student: She has a chlamydia infection. She then asks, What is chlamydia?
-
This promises to be a rocky year for federal family planning policy with potentially serious implications for the millions of low-income women who rely on Medicaid, Title X of the Public Health Service Act, and other federal programs for their family planning care.
-
New figures from the Centers for Disease Control and Prevention (CDC) show that despite an approximate 5% annual decline in the 2001-2004 rate of diagnoses among African Americans, the epidemic continues to make a severe impact on that ethnic group.
